Physician profile
Robert E Graser
NPI 1457300931
$54,101.48
in general payments reported to CMS, 2019-2025
11 companies · $81.47 in 2025
The $81.47 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,301 · 2021: $1,334 · 2022: $33.12 · 2024: $51K · 2025: $81.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $51K · Food and Beverage: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $51,260.00 |
| Food and Beverage | $172.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $51,260.00 | 2024 | |
| Pylant Medical | $2,315.00 | 2019-2021 | |
| Stryker Corporation | $142.84 | 2019 | |
| Horizon Therapeutics Plc | $122.63 | 2021 | |
| Depuy Synthes Sales INC. | $76.20 | 2024-2025 | Crosstie, Motoband |
| Treace Medical Concepts, INC. | $57.28 | 2024 | |
| Sebela Pharmaceuticals INC. | $43.28 | 2019 | |
| Orthofix Medical, INC. | $39.43 | 2025 | Physio-Stim |
| Metric Medical Devices, INC. | $20.00 | 2022 | |
| Triad Life Sciences INC. | $13.12 | 2022 | |
| Smith+Nephew, INC. | $11.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Graser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.